Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors

TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG72-positive tumors

US Patent 12281152 · Granted Apr 22, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CAR for treatment of HIV infection2025
CS1 targeted chimeric antigen receptor-modified T cells2025
Use of triplex CMV vaccine in CAR T cell therapy2025
Administration of engineered T cells for treatment of cancers in the central ner2025
Administration of engineered T cells for treatment of cancers in the central ner2025
Oncolytic virus expressing a car T cell target and uses thereof2025
Oncolytic virus expressing a car T cell target and uses thereof2025
NIR-conjugated tumor-specific antibodies and uses thereof2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Membrane-bound IL-12 for cellular immunotherapy2024
Membrane-bound IL-12 for cellular immunotherapy2024
T cells for expression of chimeric antigen receptors and other receptors2024